FdaApplication
ANDA 208112
Identifiers
- fda_app_no: ANDA208112
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LLC |
| application_type | ANDA |
| approval_date | 2024-08-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METHYLNALTREXONE BROMIDE | METHYLNALTREXONE BROMIDE | 12MG/0.6ML (12MG/0.6ML) | SOLUTION;SUBCUTANEOUS |
| METHYLNALTREXONE BROMIDE | METHYLNALTREXONE BROMIDE | 8MG/0.4ML (8MG/0.4ML) | SOLUTION;SUBCUTANEOUS |
2 products